Fundraising Fox
Klotho
Founded 2016 · 2 employees on LinkedIn · 1 known investors
Find your way into Klotho
Sign up to find every way you can get introduced to Klotho
- Your email: who you already know at Klotho, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Klotho team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Klotho Therapeutics is a biotech company developing protein-based therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney disease, diabetes, and cancer. The company focuses on longevity treatment and aims to enter human trials within two years targeting kidney disease.
Investors · 1
Thynk Capitallisted by Thynk Capitalvia Jim Plante · inferred
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Klotho do?
- Klotho Therapeutics is a biotech company developing protein-based therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney disease, diabetes, and cancer. The company focuses on longevity treatment and aims to enter human trials within two years targeting kidney disease.
- Who are Klotho's investors?
- Klotho's investors include Thynk Capital.